A World Health Organization (WHO) panel recommended use of two drugs by Eli Lilly, and GlaxoSmithKline and Vir Biotechnology for COVID-19 patients, adding treatment options as the fast-spreading Omicron variant renders many ineffective.
Coronavirus
WHO recommends Eli Lilly, GSK-Vir's drugs, widening COVID treatment
Baricitinib improves survival rate and reduces the need for ventilation, guidelines say
An Eli Lilly pharmaceutical manufacturing plant in Branchburg, New Jersey. The French medical charity Medecins Sans Frontieres said baricitinib can be a potential alternative to scarce monoclonal antibody treatments. © Reuters
Read Next
.jpg?width=178&fit=cover&gravity=faces&dpr=2&quality=medium&source=nar-cms&format=auto&height=100)
Latest on Coronavirus
